ATC Group: A02BC01 Omeprazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02BC01 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
Proton pump inhibitors
5
A02BC01
Omeprazole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
20 mg
PAREN - Parenteral
20 mg

Active ingredients in A02BC01

Active Ingredient
Description

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.

Medicines in this ATC group

Drug
Countries

Australia

South Africa

Hong Kong

Tunisia

Ireland

South Africa

Ecuador

Hong Kong

Hong Kong

Turkey

Brazil

Cyprus Hong Kong

Ecuador Estonia Hong Kong Lithuania Poland ...

Ecuador Hong Kong

Hong Kong

Tunisia

South Africa

Hong Kong

Ecuador

Ireland

Ecuador

South Africa

Ecuador Hong Kong

Hong Kong

Ireland

Hong Kong

Australia Austria Brazil Canada Cyprus ...

Netherlands

Hong Kong

Estonia Poland

Australia

United Kingdom

France Tunisia

Hong Kong

Hong Kong

South Africa

Singapore

Turkey

Lithuania

Singapore

Germany

Netherlands

Hong Kong

Romania

Ecuador

Hong Kong

Lithuania

Turkey

Estonia

Ecuador

Hong Kong

Brazil

Singapore

South Africa

Singapore

Australia Japan

Ecuador

Ecuador

Ecuador Turkey

Romania

Turkey

Hong Kong Singapore

Turkey

Finland

Ecuador

Turkey

Romania South Africa

Ecuador

Hong Kong New Zealand Singapore Tunisia

Hong Kong Singapore

Ecuador

Turkey

Singapore

South Africa

South Africa

Hong Kong

Hong Kong

Hong Kong

Turkey

Estonia Italy

Ecuador

Ecuador

Ecuador

Ecuador

Poland Romania

Australia

Ireland Netherlands New Zealand

Australia

Cyprus Singapore

Ecuador

United States

Australia New Zealand Singapore South Africa

Singapore

Singapore

Turkey

Ecuador

Singapore

Hong Kong

United Kingdom

Singapore

Hong Kong

Lithuania

Ecuador Tunisia

Singapore

Poland Romania

Singapore

South Africa

Ecuador

Estonia Lithuania Poland Romania

Lithuania

Hong Kong

Hong Kong

Hong Kong Singapore

Hong Kong

Singapore

France

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
IE
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
ZA
Summary of Product Characteristics (SPC)
IE
Structured Product Labeling (SPL/PLR)
US